Abstract
High-grade serous carcinoma (HGSC), the most prevalent histological type of ovarian cancer, has the lowest survival rates and is the leading cause in the world of gynecological cancer-related deaths. HGSC is characterized by the high frequency of mutations in the TP53 gene, genomic instability and few actionable targets for therapy. Despite an initial clinical response in most patients, r…